Your Directors are pleased to present the 12^th Annual Report along with the Audited Standalone and Consolidated Financial
Statements and Auditor's Report thereon of Trident Lifeline Limited ('Trident Lifeline' or 'Company') for the Financial Year

ended March 31, 2025.

1. FINANCIAL PERFORMANCE:

The Audited Financial Statements of your Company as on March 31, 2025, are prepared in accordance with the Regulation 33 of
the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“SEBI Listing

Regulations") and the provisions of the Companies Act, 2013 ("Act").

The summarized financial highlights is depicted below:

2. FINANCIAL HIGHLIGHTS & OPERATIONS:

The Key highlights pertaining to the business of the company
for the year 2024-25 and period subsequent there to have

been given hereunder.

• Standalone

Your Directors inform you that, during the year under review,
Your Company has revenue from operations of ? 7094.00 Lacs

and EBITDA of 7 2066.28 Lacs as against 7 4,685.52 Lacs and
? 1103.24 Lacs respectively in the previous year. During the

year under review the Company has earned net profit after tax
amounting to 7 1305.14 Lacs as against 7 704.34 Lacs in the
previous year. The Company's earnings per share were 7 11.35
during the current year. Your Directors are hopeful to achieve

better financial performance in the coming years.

• Consolidated

The consolidated total revenue of your Company for FY 2024¬
25 stood at 7 9519.58 Lacs and EBITDA of 7 2309.25 Lacs as
against 7 4670.72 Lacs and 7 1026.93 Lacs respectively in the
previous year. During the year under review the Company
has earned net profit after tax amounting to 7 1049.48Lacs
as against 7 593.97 Lacs in the previous year. The Company's
earnings per share were ? 10.22 during the current year.

A detailed discussion on financial and operational performance
of the Company is given under "Management Discussion and
Analysis Report" forming part of this Annual Report.

3. CHANGE IN THE NATURE OF THE BUSINESS:

During the year, there was no change in the nature of Business
of the Company.

4. CHANGE IN SHARE CAPITAL:

During the financial year under review, there has been no
change in Share Capital of the Company. The Company's
shares are listed on BSE Limited (Scrip Code: 543616).

5. STATEMENT OF DEVIATION(S) OR VARIATION(S)
IN ACCORDANCE WITH REGULATION 32 OF SEBI
(LODR) REGULATIONS, 2015:

In accordance with the offer document of the Initial Public Offer,

the Company had estimated utilization of T 2050 Lacs towards
Funding Working Capital requirements of the Company, ?

513.66 Lacs towards Product registration in international
markets, T 670.53 Lacs towards General Corporate Purposes
and T 300 Lacs towards public issue expenses.

The actual utilization as on 31^st March, 2025 was T 2005.06
Lacs towards Funding Working Capital requirements of
the Company, T 51.55 Lacs towards Product registration
in international markets, T 670.48 Lacs towards General
Corporate Purposes and ? 300.00 Lacs towards public issue
expenses. Remaining unutilized amount lying with the bank.

6. PUBLIC DEPOSITS:

Your Company has not accepted or renewed any Public
Deposits within the meaning of Section 73 and 74 of the Act

read with rules made thereunder at the end of the FY 2024-25
or the previous financial years.

7. APPROPRIATIONS:

• Dividend:

The Board of directors does not recommend a dividend for the
year under review.

• Transfer to Reserve:

The Board of Directors have not proposed to transfer any
amount to any Reserve. Therefore, entire profits of ? 1305.14

Lakhs earned during the financial year 2024-25 have been
retained in the profit and loss account.

• Bonus Shares:

During the year the Company has not allotted any Bonus
Shares to its members.

8. RIGHT ISSUE:

During the year the Company has not issued any Right shares
to its members.

9. DEPOSITORY SYSTEM:

As members are aware, the company's shares are compulsorily
tradable in the electronic form. As on March 31, 2025, 100% of
the Company's total paid-up capital representing 1,14,99,200
shares were in dematerialized form. The ISIN of the Equity
Shares of your Company is INE0MKA01014.

10. CREDIT RATING:

The Company has not obtained Credit Rating from any Credit
Rating Agency as on the date of this Report.

11. DETAILS OF LOANS/INVESTMENTS/
GUARANTEES:

The Companies has provided loans/guarantees to its
subsidiaries, associates and other parties and has made
investments during the year in compliance with provisions
of the Companies Act, 2013 and rules made thereunder.
The details of such loans/guarantees provided as on March
31, 2025 are provided in Note No. 11, 13, 18 and 29 of the
Standalone Financial Statements.

12. DISCLOSURES RELATING TO SUBSIDIARIES,
ASSOCIATES AND JOINT VENTURES:

At the beginning of the year, the Company had three Subsidiary
Companies-TNS Pharma Private Limited, TLL Parenterals
Limited and TLL Herbal Limited and during the year under
review:

TLL Elements Private Limited was incorporated as wholly-
owned subsidiary company pursuant to subscription of 100%

equity shares w.e.f. April 15, 2024.

The Company has successfully completed the subscription
of 51% of the issued and paid up capital of the Company TLL
Parenterals Limited and Trident Mediquip Limited with effect
from December 02, 2024 and February 04, 2025 respectively.

T-Med Biovation Private Limited, being subsidiary of Trident
Mediquip Limited became step-down subsidiary of the
company and subsequently ceased to be step-down subsidiary
with effect from March 27, 2025 due to dis-investment by

Trident Mediquip Limited.

Except above, no other company has become or ceased to be
subsidiary, joint venture or associate company during the year
under review.

13. SUBSIDIARY COMPANIES AND ITS FINANCIAL
PERFORMANCE:

During the year under review, the Company had five (5)
subsidiaries viz. TNS Pharma Private Limited, TLL Herbal
Limited, TLL Elements Private Limited, TLL Parenterals Limited
and Trident Mediquip Limited. Pursuant to the provisions of
Section 129, 134 and 136 of the Act read with rules made
thereunder and Regulation 33 of the SEBI Listing Regulations,
the Company has prepared consolidated financial statements
and a separate statement containing the salient features
of financial statement of subsidiaries in Form AOC-1 as
Annexure-F, which forms part of this Annual Report.

The Annual Financial Statements and related detailed
information of the subsidiary companies shall be made
available to the shareholders of the holding and subsidiary
companies seeking such information on all working days
during business hours.

14. BOARD OF DIRECTORS:

As on March 31, 2025, your Company's Board had 6 members comprising 3 Executive Directors and 1 Non-Executive and Non¬
Independent Director and 2 Non-Executive & Independent Directors. The Board have 3 women Directors out of total directors as
under:

The Directors of your Company are well experienced having
expertise in their respective fields of technical, finance,
strategic and operational management and administration.

During the year following changes in directorship were
made:

Ms. Aena Surana (DIN: 09652356), has resigned from the
post of Independent Director w.e.f. April 27, 2025 due to her
personal reasons and other professional commitments.

The Board has placed on record its sincere appreciation

for efficient and mature advice by Ms. Aena Surana as an
Independent Director of the Company.

Mrs. Falguni Bhavesh Jariwala (DIN: 1058471 1) was appointed
as an Independent Non-Executive Director (Additional

Director) designated as Women Director on April 27, 2025
and was regularized by the members through Postal Ballot on
June 20, 2025.

Mr. Mayurkumar Mansukhbhai Gajera (DIN: 08629139), has
resigned from the post of Whole Time Director and Chief

Financial Officer w.e.f. May 16, 2025 due to his personal
reasons and pre-occupation elsewhere.

The Board has placed on record its sincere appreciation for

efficient and mature advice by Mr. Mayurkumar Gajera as
Whole Time Director & Chief Financial Officer of the Company.

Mrs. Rupaben Chetan Jariwala (DIN: 08543127) was appointed
as an Additional Director designated as Whole Time Director

& Key Managerial Personnel of the Company on May 16, 2025
and was regularized by the members through Postal Ballot on
June 20, 2025.

Mrs. Maniya Hardik Desai (DIN: 05351685) retires by rotation
and being eligible, offers herself for re-appointment.
A resolution seeking Shareholders' approval for her re¬
appointment along with other required details forms part of
the Notice.

None of the Directors of your Company are disqualified under
the provisions of Section 164(2)(a) and (b) of the Act.

In the opinion of the Board, the Independent Directors
appointed during the year possess requisite integrity,

expertise, experience and proficiency.

The composition of Board complies with the requirements of
the Companies Act, 2013. Further, in pursuance of Regulation
15(2) of SEBI (Listing Obligations and Disclosure Requirements)
Regulations, 2015 ("Listing Regulations"), the Company is
exempted from requirement of having composition of Board
as per Listing Regulations.

15. KEY MANAGERIAL PERSONNEL:

Pursuant to the provisions of section 203 of the Companies
Act, 2013 read with rules framed thereunder the following

persons are the key Managerial Personnel of the company as
on March 31, 2025:

1) Mr. Shravan H Patel, Managing Director.

2) Mrs. Rupaben Chetan Jariwala, Whole Time Director.

3) Mr. Ashish Anandsign Bafna, Chief Financial Officer

4) Mrs. Nikita Sharma, Company Secretary and Compliance
Officer.

Mr. Mayurkumar Mansukhbhai Gajera has resigned from the
post Whole Time Director & Chief Financial Officer w.e.f. May

16, 2025 and Mr. Ashish Anandsign Bafna was appointed as
Chief Financial Officer of the Company on July 17, 2025.

Mr. Jiteshkumar R Varkal has resigned from the post of
Company Secretary and Compliance Officer of the Company
w.e.f. May 30, 2025.

Mrs. Nikita Sharma was appointed as Company Secretary and
Compliance officer of the Company w.e.f. August 31, 2025.

16. DISCLOSURE RELATED TO BOARD, COMMITTEES AND POLICIES:

1. Board Meetings:

The Board of Directors met 15 times during the financial year ended March 31, 2025 in accordance with the provisions of the
Companies Act, 2013 and rules made there under as under:

Attendance of Directors at Board Meetings

2. Committee Meetings:

Audit Committee

As on March 31,2025, the Audit Committee of the Board comprises of three members viz; Mr. Mishal Shailesh Patel (Independent

and Non- Executive Director)-Chairman, Mrs. Falguni Bhavesh Jariwala (Independent and Non- Executive Director)- Member and
Mrs. Rupaben Chetan Jariwala (Whole Time Director)- Member.

All recommendations made by the Audit Committee were accepted by the Board during the year 2024-2025. The Audit Committee

met 07 times during the Financial Year ended March 31, 2025 as mentioned below:

Nomination and Remuneration Committee

As on March 31, 2025, the Nomination and Remuneration Committee of the Board comprises of three members viz; Mr. Mishal

Shaiiesh Patel (Independent and Non- Executive Director)-Chairman, Mrs. Faiguni Bhavesh Jariwaia (Independent and Non¬
Executive Director)- Member and Mrs. Maniya Hardik Desai (Non-Executive Director)- Member, all of which are Non- Executive
Directors.

The Nomination and Remuneration Committee and the Policy are in compliance with Section 178 of the Companies Act, 2013
read with the applicable rules thereto and Listing Regulations (as may be amended from time to time). The Nomination and
Remuneration Committee has met 04 times during the period ended March 31, 2025 as mentioned below:

Stakeholders Relationship Committee

The Stakeholders Relationship Committee of the Board comprises of three members viz; Mrs. Maniya Hardik Desai (Non-Executive

Director)- Chairperson, Mr. Mishal Shailesh Patel (Independent & Non-Executive Director)-Member, Mr. Hardik J Desai (Chairman &
Executive Director)- Member. The Stakeholders Relationship Committee has met 01 time during the Year ended March 31, 2025

on March 26, 2025.

Details of Investors grievances/Complaints

No investor complaints received during the financial year 2024¬
25. No pending complaints of the Shareholders/Investors

registered with SEBI at the end of the current financial year
ended on March 31, 2025. There were no pending requests
for share transfer/dematerialization of shares as of March 31,
2025.

3. Meeting of Independent Directors:

A separate meeting of the independent directors of the

company for the Financial Year 2024-25 was held on March 26,
2025 where all the Independent Directors were present as per
the requirement of Regulation 25 of SEBI (Listing Obligations
and Disclosure Requirements) Regulations, 2015.

17. FAMILIARIZATION PROGRAM FOR
INDEPENDENT DIRECTORS:

A policy on familiarization programs for independent directors
has been adopted by the Company. All new Independent
Directors inducted to the Board are presented with an
overview of the Company's business operations, products,

organization structures and about the Board Constitutions
and its procedures. The policy is available at the company's
website www.tridentlifeline.com.

18. EVALUATION OF BOARD'S PERFORMANCE:

The Board of Directors has carried out an annual evaluation
of its own performance, board committees, and individual
directors pursuant to the provisions of the Act and SEBI.

Listing Regulations. The performance of the board was
evaluated by the Board after seeking inputs from all the
directors on the basis of criteria such as the board composition
and structure, effectiveness of board processes, information
and functioning, etc.

The performance of the committees was evaluated by the
Board after seeking inputs from the committee members on
the basis of criteria such as the composition of committees,
effectiveness of committee meetings, etc.

In a separate meeting of Independent Directors held on
March 26, 2025, performance of non-independent Directors,

performance of Board as a whole and performance of the
Chairman were evaluated taking into account the views of

executive and non-executive Directors. The said meeting was
attended by all the Independent Directors.

The performance of the Board and its Committees, individual
Directors, and Chairpersons were found satisfactory. Further,
the Board has expressed its satisfaction and has been thankful
to all its Independent Directors for sharing their knowledge

and expertise which has been proved beneficial towards the
progress of the Company.

19. DECLARATIONS BY INDEPENDENT DIRECTORS:

The Company has received a necessary declaration from
each independent director that he/she meets the criteria
of independence laid down in Section 149(6), Code for
independent directors of the Act and Regulation 16(1)(b) of

the Listing Regulations.

20. PARTICULARS OF REMUNERATION OF DIRECTORS AND EMPLOYEES:

The managerial remuneration paid to the directors during the financial year are as under:

Further the managerial remuneration of T 20.76 Lacs and
T 0.54 Lacs paid to Mr. Hardik Desai and Mrs. Maniya Hardik
Desai respectively for the financial year 2024-25 were found

in excess of the maximum permissible limit as prescribed
under Section 197 of the Act from the total managerial
remuneration paid, but the said remuneration was within the
limits as approved by the members at previous AGM held on
September 21, 2023.

Disclosures relating to remuneration and other details as
required in terms of the provisions of Section 197(12) of the

Act read with Rule 5(1) of the Companies (Appointment and
Remuneration of Managerial Personnel) Rules, 2014 are given
in Annexure-A which forms part of this Report.

Further, no employee of the Company was in receipt of the
remuneration exceeding the limits prescribed in the rule

5(2) of the Companies (Appointment and Remuneration of
Managerial Personnel) Rules, 2014, hence no information as
required under the provisions of Section 197 of the Companies
Act, 2013 read with rule 5(2) and 5(3) of the Companies
(Appointment and Remuneration of Managerial Personnel)
Rules, 2014 are provided in this report.

In accordance with Section 178 of the Companies Act, 2013
and Regulation 19 of the Listing Regulations, the Nomination

and Remuneration Committee of the Board of Directors
approved the 'Nomination and Remuneration Policy', which is
available on the website of the Company www.tridentlifeline.
com.

21. DIRECTORS' RESPONSIBILITY STATEMENT:

Pursuant to the requirement under Section 134(3)(c) read
with 134(5) of the Act, your Directors confirm that:

(a) The applicable accounting standards have been
followed along with proper explanation relating to
material departures, if any, in the preparation of the
annual accounts;

(b) Appropriate accounting policies have been selected
and applied consistently and judgments and estimates
have been made that are reasonable and prudent so
as to give a true and fair view of the state of affairs of
the Company at the end of the financial year and of the
profit of the Company for that period;

(c) Proper and sufficient care has been taken for the
maintenance of adequate accounting records
in accordance with the provisions of this Act for
safeguarding the assets of the Company and for
preventing and detecting fraud and other irregularities;

(d) The annual accounts have been prepared on a going
concern basis;

(e) Proper internal financial controls have been laid down
and followed by the Company and that such internal
financial controls are adequate and were operating
effectively; and

(f) Proper systems to ensure compliance with the
provisions of all the applicable laws have been devised
and that such systems were adequate and are working
effectively.

Based on the framework of internal financial controls
and compliance systems established and maintained
by the Company, the work performed by the internal,

statutory and secretarial auditors and external
consultants, including the audit of internal financial
controls over financial reporting by the statutory

auditors and reviews performed by the management
and relevant Board Committee, the Board is of the
opinion that the Company's internal financial controls
were adequate and effective during the financial year
2024-2025.

22. CORPORATE GOVERNANCE:

Pursuant to the provisions of Regulation 15 of the SEBI (Listing
Obligations and Disclosure Requirements) Regulations, 2015
("Listing Regulations"), the Company is exempted from

Reporting on Corporate Governance and therefore the
Company is not filing Corporate Governance Report to the
Stock Exchange and hence the Report is not attached with this
Report. However, the Company is complying with the provision
of filing Corporate Governance Non-Applicability Certificate to
the Exchange.

Report on Corporate Governance Practices and the Certificate
regarding compliance of conditions of Corporate Governance
and certification by CEO/Whole time Director & CFO is not
applicable to your Company as per regulation 15(2)(b) of SEBI
(Listing Obligation and Disclosure Requirements) Regulations,
2015.

23. CORPORATE SOCIAL RESPONSIBILITY POLICY:

At present, amount to be spent by a company under sub¬
section (5) of Section 135 of the Companies act, 2013 does
not exceed fifty lakh rupees, therefore the requirement under
sub-section (1) of section 135 of the Companies act, 2013 for
constitution of the Corporate Social Responsibility Committee
shall not be applicable and the functions of such Committee
provided under this section shall be discharged by the Board
of Directors of company.

This CSR Policy has been approved by the Board of directors of

the Company dated 6^th May, 2023 (“the Board").

The CSR policy, covering the Objectives, Focus Areas,
Governance Structure Monitoring and Reporting Framework

among others is approved by the Board of Directors. The
CSR Policy is available on the website of the Company and
can be accessed at www.tridentlifeline.com. The main
objective of Trident Lifeline's CSR policy is to make CSR a key
business process for sustainable development of society. In
its endeavors to mutually achieve the said objective, the Act
stipulates the provisions regarding mandatory adherence to
the Corporate Social Responsibility practices by the prescribed
classes of companies.

The Company has spent more than 2% of the average
net profits of the Company during the three immediately

preceding Financial Years on CSR.

The Annual Report on CSR activities, in terms of Section 135 of
the Companies Act, 2013 and the Rules framed thereunder, is

annexed to this Report (Annexure-B).

24. VIGIL MECHANISM/WHISTLE BLOWER POLICY:

The company has a Whistle about the unethical behavior, fraud
or violation of Company's code of conduct. Blower Policy for
the vigil mechanism of Directors and employees to report

to the management the mechanism provides for adequate
safeguards against victimization of employees and Directors

who use such mechanism and makes provision for direct access
to the chairman of the Audit Committee in exceptional cases.
None of the personnel of the Company have been denied

access to the Audit Committee. The Whistle Blower Policy is
displayed on the Company's website viz. www.tridentlifeline.
com.

25. PREVENTION OF INSIDER TRADING:

The Company has adopted an Internal Code of Conduct for
Regulating, Monitoring and Reporting of Trades by Insiders
("the Code") in accordance with the SEBI (Prohibition of Insider
Trading) Regulations, 2015(The PIT Regulations).The Code is

applicable to Promoters and Promoter's Group, all Directors
and such Designated Employees who are expected to have
access to unpublished price sensitive information relating
to the Company. The Company Secretary is the Compliance
Officer for monitoring adherence to the said PIT Regulations.

The Company has also formulated 'The Code of Practices and
Procedures for Fair Disclosure of Unpublished Price Sensitive
Information (UPSI)' in compliance with the PIT Regulations.

This Code is displayed on the Company's website viz. www.
tridentlifeline.com.

26. CODE OF CONDUCT:

The Company has adopted Code of Business Conduct & Ethics
("the Code") which is applicable to the Board of Directors,
Senior Management, Key Managerial Personnel, Functional
heads and all professionals serving in the roles of finance, tax,
accounting, purchase and investor relations of the Company.
The Board of Directors and the members of the Senior
Management Team (one level below the Board of Directors)
of the Company are required to affirm annual Compliance of
this Code. A declaration signed by the Chairman and Managing
Director of the Company to this effect is placed at the end of
this report as Annexure-C.

The Code requires Directors and Employees to act honestly,

fairly, ethically and with integrity, conduct themselves in a
professional, courteous and respectful manner. The Code is
displayed on the Company's website viz. www.tridentlifeline.
com.

27. PREVENTION OF SEXUAL HARASSMENT AT THE
WORKPLACE:

The Company is conscious of the importance of environmentally

clean and safe operations. The Company's policy requires
conduct of operations in such a manner so as to ensure safety of
all concerned, compliances of environmental regulations and
preservation of natural resources. As required by the Sexual
Harassment of Women at Workplace (Prevention, Prohibition
& Redressal) Act, 2013, the Company has formulated and
implemented a policy on prevention of sexual harassment
at the workplace with a mechanism of lodging complaints.
Besides, redressal is placed on the intranet for the benefit of
employees.

Following is a summary of sexual harassment complaints
received and disposed of during F.Y. 2024-2025.

No. of complaints not resolved as on 1^st April, 2024: Nil

No. of complaints received in financial year 2024-25: Nil

No. of complaints resolved in financial year 2024-25: Nil

No. of complaints not resolved as on 31^st March, 2025: Nil

28. STATUTORY AUDITORS AND INDEPENDENT
AUDITORS' REPORT:

M/s. A Bafna & Associates., Chartered Accountants, (Firm
Registration No. 121901W) have been appointed as the
Statutory Auditor of your Company for a tenure of 5 (five)

years till the 14^th AGM to be held in the Calendar Year 2027. The
Auditors' Report given by M/s. A Bafna & Associates, Statutory
Auditor, on the Financial Statements of your Company, for the
year ended March 31, 2025, forms part of the Annual Report.

It is stated in the report that the remuneration paid
by the Company to its directors during the year under
review is in excess of the limit laid down under Section
197 of the Companies Act, 2013.

The Board would like to clarify that the managerial remuneration
of f 20.76 Lacs and f 0.54 Lacs paid to Mr. Hardik Desai and
Mrs. Maniya Hardik Desai respectively for the financial year
2024-25 were found in excess of the maximum permissible
limit as prescribed under Section 197 of the Act from the total
managerial remuneration paid, but the said remuneration was
within the limits as approved by the members at previous AGM
held on September 21, 2023.

Apart from this, there is no qualification, reservation or
adverse remark or any disclaimer in their Report. The Auditors'
Report for the year is self-explanatory & does not contain any
modified opinion, hence need no comments.

29. REPORTING OF FRAUDS:

There have been no frauds reported under sub-section (12) of
Section 143 of the Act, during the financial year under review,
to the Audit Committee or the Board of Directors.

30. SECRETARIAL AUDITOR AND SECRETARIAL
AUDIT REPORT:

The Company has appointed M/s. Amareliya & Associates,
Practicing Company Secretary (ICSI M. No. F12452, COP:
24321, PR: 4735/2023) as the Secretarial Auditor for the
financial year 2024-25 in accordance with Section 204 of the
Act. The Report on Secretarial Audit for the Financial Year
2024-25, in Form MR-3, is annexed hereto as Annexure-D and
forms part of this Report.

The Secretarial Audit Report contains following
qualification, reservation or adverse remark:

There was delay in compliance of Regulation 6(1A) of the SEBI
(Listing Obligations and Disclosure Requirements) Regulations
2015 (‘the SEBI (LODR) Regulations, 2015') w.r.t. filing casual
vacancy of Compliance Officer of the Company, Mr. Jitesh
Ramchandrabhai Varkal (ICSI M. No. A31727 had resigned as
Company Secretary and Compliance Officer effective May 30,
2024 and the Company has appointed Mrs. Nikita Sharma (ICSI M.
No. A60595) as the Company Secretary of the Company effective
August 31, 2024.

Management Reply

The Company was persistently seeking an appropriate
candidate for the role of Company Secretary and compliance
officer to address the casual vacancy. As soon as the Company
identified the suitable candidate, an immediate appointment
was made. Therefore, there was no malicious intent regarding
the delay in appointing the Company Secretary.

The company has not filed e-form MSME for the half year ended
March 31, 2024 & September 30, 2024 with RoC still as on date.

Explanation to Auditors comment:

Due to an oversight or inadvertent mistake, the form was not
filed within the stipulated time frame.

31. SECRETARIAL STANDARDS:

The Company has complied with all the applicable secretarial
standards issued by the Institute of Company Secretaries of
India.

32. INTERNAL AUDITORS:

Pursuant to the provisions of Section 138 of the Companies

Act, 2013, the Board of Directors of the Company have
appointed M/s. DAC & Co., Chartered Accountant, having FRN
No. 137035W as an Internal Auditor of the Company on April
27, 2024 for the financial year 2024-25.

The audit committee of the Board of Directors in consultation
with the Internal Auditor formulates the scope, functioning,
periodicity and methodology for conducting the internal audit.

33. COST RECORDS AND AUDIT:

The Company has not appointed the Cost Auditor as pursuant
to Section 148 of the Companies Act, 2013 read with the
Companies (Cost Records and Audit) Amendment Rules, 2014,

the cost audit is not applicable to the Company.

34. INTERNAL CONTROL SYSTEM:

Your Company has put in place adequate internal financial
controls with reference to the financial statements. The
Board has adopted the policies and procedures for ensuring
the orderly and efficient conduct of its business including
adherence to the Company's policies, the safeguarding of
its assets, prevention and detection of frauds and errors,
accuracy and completeness of the accounting records and
timely preparation of reliable financial disclosures. During the
year, such controls were tested and no reportable material
weaknesses in design or operation were observed. The
Internal Auditor certifies on the assurance of adequacy of
Internal Control System on quarterly basis which are regularly
reviewed by the Audit Committee. Independence of the audit
is ensured by the direct reporting of internal audit functions to
the Audit Committee of the Board.

35. RISK MANAGEMENT:

Risk Management is the systematic process of understanding,
measuring, controlling and communicating an organization's
risk exposures while achieving its objectives. Risk Management
is an important business aspect in the current economic
environment and its objective is to identify, monitor and
take mitigation measures on a timely basis in respect of the
events that may pose risks for the business. The Company's
risk-management strategy is to identify, assess and mitigate
any significant risks. We have established processes and
guidelines, along with a strong overview and monitoring
framework at the Board and Senior Management levels. The
Board of Directors regularly reviews risks and threats and
takes suitable steps to safeguard its interest and that there is
no element of risk identified that may threaten the existence
of the Company. The focus shifts from one area to another
area depending upon the prevailing situation. A detailed

report on significant risks and mitigation is forming part of

Management's Discussion and Analysis.

36. INSURANCE:

The Company has taken all the necessary steps to insure its
properties and insurable interests, as deemed appropriate and
also as required under the various legislative enactments.

37. INVESTOR EDUCATION AND PROTECTION
FUND: -

During the year under review, the Company has not transferred
any amount to the Investor Education and Protection Fund.

38. LOAN FROM DIRECTORS:

During the year under reporting, the Company has taken
T 641.00 Lacs Unsecured Loan from directors and relatives
of directors and repaid T 456.00 Lacs. Pursuant to rule 2(c)
(viii) of the Companies (Acceptance of Deposits) Rules, 2014
declaration has been received from them that the amount
has not been given out of the funds acquired by them, either
by borrowings or by accepting loans or deposits from others.
Refer Note No. 29 (B) of the Financial Statement.

39. RELATED PARTY TRANSACTIONS:

There have been no materially significant related party
transactions with the Company's Promoters, Directors and
others as defined in Section 2(76) of the Companies Act, 2013

which may have potential conflict of interest with the Company
at large.Further, all such contracts/arrangements/transactions
were placed before the Audit Committee and Board, for their
approval. Prior approval/s of the Audit Committee/Board are
obtained on an annual basis, which is reviewed and updated
on quarterly basis.

All related party transactions entered into during the financial
year were on an arm's length basis and were in the ordinary
course of business. Your Company had not entered into any
transactions with related parties which could be considered
material in terms of Section 188 of the Act. Accordingly, the
disclosure of related party transactions, as required under
Section 134(3)(h) of the Act, in Form AOC - 2, is not applicable.

40. PARTICULARS RELATING TO CONSERVATION
OF ENERGY, TECHNOLOGY ABSORPTION, FOREIGN
EXCHANGE EARNINGS AND OUTGO:

A statement giving details of conservation of energy,

technology absorption, foreign exchange earnings and outgo,
in accordance with Section 134(3)(m) of the Act, read with the
Rule 8(3) of the Companies (Accounts) Rules, 2014, is annexed

as "Annexure-E" hereto and forms part of this report.

41. EQUAL EMPLOYMENT OPPORTUNITIES:

Being an equal opportunity employer, the company will do its

utmost to ensure that all of its employees are treated fairly
during the period of their employment irrespective of their
race, religion, sex (including pregnancy), color, creed, age,

national origin, physical or mental disability, citizenship status,
ancestry, marital status veteran status, political affiliation,
or any other factor protected by law. All decisions regarding
employment will be taken based on merit and business needs
only.

42. ANNUAL RETURN:

In Compliance with the provision of Section 92(3) and Section
134(3)(a) of the Companies Act, 2013, the draft Annual Return
in Form MGT-7 for the Financial Year 2024-24, is made available
on the website of the Company at https://www.tridentlifeline.
com.

43. MATERIAL CHANGES AND COMMITMENTS
AFTER THE CLOSURE OF THE FINANCIAL YEAR TILL
THE DATE OF THIS REPORT, WHICH AFFECTS THE
FINANCIAL POSITION OF THE COMPANY.

The company had issued 9,94,200 fully convertible warrants on

preferential basis to promoters and non-promoter category in
accordance with provisions specified under Chapter V of SEBI
(ICDR) Regulations, 2018, out of which 93,000 warrants have

been converted into equity shares.

44. COMPLIANCE WITH THE MATERNITY BENEFIT
ACT, 1961:

The Company has complied with the provisions of the Maternity

Benefit Act, 1961, including all applicable amendments
and rules framed thereunder. The Company is committed
to ensuring a safe, inclusive, and supportive workplace for
women employees. All eligible women employees are provided
with maternity benefits as prescribed under the Maternity
Benefit Act, 1961, including paid maternity leave, nursing
breaks, and protection from dismissal during maternity leave.
The Company also ensures that no discrimination is made in
recruitment or service conditions on the grounds of maternity.
Necessary internal systems and HR policies are in place to
uphold the spirit and letter of the legislation.

45. GENERAL:

Your Directors state that no disclosure or reporting is required

in respect of the following items as there were no transactions
on these items during the year under review:

a. Issue of Equity Shares with differential rights as to
dividend, voting or otherwise.

b. Issue of Shares (including sweat equity shares) to
employees of the Company under any scheme.

c. No significant or material orders were passed by the
Regulators or Courts or Tribunals which impact the
going concern status and Company's operations in
future.

d. There was no proceeding initiated/pending against your
Company under the Insolvency and Bankruptcy Code,
2016.

e. The Company has not made any one-time settlement for
loans taken from the Banks or Financial Institutions, and
hence the details of difference between amount of the
valuation done at the time of one time settlement and
the valuation done while taking loan from the Banks or
Financial Institutions along with the reasons thereof is
not applicable.

46. ACKNOWLEDGEMENTS:

The Directors thank the Company's customers, vendors,
investors, lenders, bankers, Government and Regulatory
Authorities and Stock Exchange and all other stakeholders for
their continuous support.

The Directors also thank the Government of India, Governments
of various states in India, Governments of various countries

and concerned Government departments and agencies for
their co-operation.

The Directors appreciate and value the contribution made
by all our employees and their families and the contribution
made by every other member of the Trident Lifeline's family,

for making the Company what it is.

For and on behalf of the Board of Directors
Trident Lifeline Limited

Hardik J. Desai Shravan H Patel

Date: September 01, 2025 Chairman & Executive Director Managing Director

Place: Surat DIN: 01358227 DIN: 08629141